Document is current
Any future updates will be listed below
-
Authors
Lee, Seok
Kim, Hyeoung-Joon
Cheong, June-Won
Shin, Ho-Jin
Kong, Jee Hyun
Sohn, Sang Kyun
Yoon, Sung-Soo
Zang, Dae Young
Jung, Chul Won
Kim, Jeong-A
Lee, Sung-Eun
Lee, Won Sik
Choi, Yunsuk
Kim, Inho
Han, Jae Joon
Kim, Min Kyoung
Chong, So Young
Kim, Da Jung
Jo, Deog-Yeon
Kim, Hawk
Kwak, Jae-Yong
Lee, Je-Hwan
Uhm, Jieun
Lee, Sewon
Lee, Min-Yi
Kim, Dong-Wook
-
Funding
Funding for this research was provided by:
Korea Otsuka Pharmaceutical Co., Ltd
- License Information
-
More Information
Article History
Received: 22 December 2025
Accepted: 1 May 2026
First Online: 22 May 2026
Declarations
:
: This study was approved by the Institutional Review Board at each study site, and conducted in accordance with the Declaration of Helsinki and local regulations.
: Dong-Wook Kim has received grants, honoraria for lectures, presentations and speaker bureaus from Bristol Meyers Squibb, Novartis, Pfizer, Il-Yang and Korea Otsuka Pharmaceutical.
: Informed consent was obtained from all patients for their clinical information to be used for publication.
